Image credit: Alyson Martin

SAMHSA: Newly Popular Cannabis Compounds Are Complicating Impairment Testing

The FDA’s work on CBD, a drop in military members testing positive for cannabis, and other cannabis-related topics were on the agenda at a federal Drug Testing Advisory Board meeting this week.

Research
Regulation

National Academies’ Cannabis Committee Convenes Again

The second meeting of the Committee on the Public Health Consequences of Changes in the Cannabis Policy Landscape is underway this week. Here’s what happened on day one.